Edward L. Snyder

Biography

Dr. Edward Snyder is an internationally known Transfusion Medicine expert, who has served on over 130 National Institutes of Health Study Section, Committee and SEP positions, many as Chair. Dr. Snyder has been a consultant and reviewer for the FDA. He is a past Board Chair of the National Marrow Donor Program and a past President of the American Association of Blood Banks. He was Chair of the American Society of Hematology Subcommittee on Transfusion Medicine for several terms and is currently an associate editor of the journal Transfusion.  Dr. Snyder is currently Primary Investigator (PI) on the Yale-National Heart, Lung and Blood Institute (NHLBI), REDS-III contract. This contract REDS-III (Recipient Epidemiology and Donor Evaluation Study – III) is designed to evaluate the use of blood and blood products in patients and to determine the incidence of adverse events in blood transfusion recipients. He is also studying the role of pathogen reduction on the blood supply and is Yale site PI on an FDA-required Phase IV evaluation of a recently approved pathogen reduction technology using UV-A and psoralen to inactivate blood borne pathogens. Dr. Snyder also runs the Apheresis Core Laboratory at Yale, which provides human white cells to researchers at the medical center. Dr. Snyder receives extramural funding from the NHLBI as PI of the REDS-III contract, as well as extramural funding from industry as regards the Pathogen Reduction observational study alluded to above. He has received several R13 grants from NHLBI to conduct cutting-edge conferences on topics in Transfusion. He has published and presented over 350 publications, book chapters and abstracts. Dr. Snyder received his medical degree from New York Medical College. 

Research Interest

 Haematology